A detailed history of Benedetti & Gucer, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Benedetti & Gucer, Inc. holds 20,245 shares of OGN stock, worth $298,208. This represents 0.19% of its overall portfolio holdings.

Number of Shares
20,245
Previous 19,575 3.42%
Holding current value
$298,208
Previous $282,000 35.11%
% of portfolio
0.19%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$13.78 - $18.8 $9,232 - $12,596
670 Added 3.42%
20,245 $381,000
Q4 2023

Feb 12, 2024

BUY
$10.95 - $17.32 $5,913 - $9,352
540 Added 2.84%
19,575 $282,000
Q3 2023

Nov 02, 2023

BUY
$16.59 - $23.77 $19,410 - $27,810
1,170 Added 6.55%
19,035 $330,000
Q2 2023

Jul 20, 2023

BUY
$19.27 - $24.63 $8,671 - $11,083
450 Added 2.58%
17,865 $372,000
Q1 2023

Apr 26, 2023

BUY
$21.42 - $32.08 $373,029 - $558,673
17,415 New
17,415 $410,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Benedetti & Gucer, Inc. Portfolio

Follow Benedetti & Gucer, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedetti & Gucer, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benedetti & Gucer, Inc. with notifications on news.